4426 - 4450 of 8801 Results
Title
Year
-
OPENTitle: Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responsesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01159-wBest OA location URL: https://www.nature.com/articles/s41531-025-01159-w.pdfCitation Count: 0
-
RESTRICTEDTitle: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 309Issue #:Start Page: 91End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016Citation Count: 48
-
RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0
-
OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 80
-
RESTRICTEDTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 5
-
OPENTitle: Lifestyle factors and clinical severity of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-31531-wBest OA location URL: https://www.nature.com/articles/s41598-023-31531-w.pdfCitation Count: 12
- Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients2025RESTRICTEDTitle: Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107951End Page: 107951Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107951Citation Count: 0
-
OPENTitle: Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain TissueJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 18Start Page: 1477End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14181477Best OA location URL: https://doi.org/10.3390/cells14181477Citation Count: 0
-
RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
-
OPENTitle: Phosphorylation of Parkin at serine 65 is essential for its activationin vivoJournal Name: Open BiologyPublisher: The Royal SocietyVol: 8Issue #: 11Start Page: 180108End Page: 180108Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.180108Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2020-06682%22Citation Count: 111
-
RESTRICTEDTitle: Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2469End Page: 2478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10812-2Citation Count: 24
-
RESTRICTEDTitle: Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 224End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.003Citation Count: 3
-
OPENTitle: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5573415Citation Count: 23
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 11
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9733952Citation Count: 12
-
OPENTitle: The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s DiseaseJournal Name: Aging, Neuropsychology, and CognitionPublisher: Informa UK LimitedVol: 27Issue #: 4Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13825585.2019.1653445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8763139Citation Count: 23
-
OPENTitle: Current disease modifying approaches to treat Parkinson’s diseaseJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 73Issue #: 7Start Page: 1365End Page: 1379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1Best OA location URL: http://hdl.handle.net/10138/223922Citation Count: 95
-
OPENTitle: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's DiseaseJournal Name: Advanced MaterialsPublisher: WileyVol: 35Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adma.202304654Best OA location URL: https://doi.org/10.1002/adma.202304654Citation Count: 58
-
OPENTitle: Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00652-yBest OA location URL: https://www.nature.com/articles/s41531-024-00652-y.pdfCitation Count: 7
-
OPENTitle: Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar typeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 199End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.006Best OA location URL: http://www.prd-journal.com/article/S1353802019300379/pdfCitation Count: 25
- Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes2025OPENTitle: Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01147-0Best OA location URL: https://www.nature.com/articles/s41531-025-01147-0.pdfCitation Count: 0
- Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers2025RESTRICTEDTitle: Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markersJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 478Issue #:Start Page: 123731End Page: 123731Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2025.123731Citation Count: 0
-
RESTRICTEDTitle: Serum L-ornithine-derived polyamines as indicators of Parkinson disease progressionJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-025-03007-wCitation Count: 0
-
RESTRICTEDTitle: Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersJournal Name: CortexPublisher: Elsevier BVVol: 49Issue #: 9Start Page: 2501End Page: 2511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2012.12.017Citation Count: 45
-
OPENTitle: Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab281Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab281/41780538/fcab281.pdfCitation Count: 23